Beyond the above effects, two recent studies pointed towards the role of CerS6 in energy expenditure, diet-induced steatohepatitis and insulin resistance thus underscoring it as a possible therapeutic target for treating metabolic diseases associated with obesity [48, 49]. This evidence concerns the gene CERS6 and Insulin resistance.